about
Molecular mechanisms of peritoneal dissemination in gastric cancerDiversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular PerspectivesChemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesCXCR4 over-expression and survival in cancer: a system review and meta-analysisCXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathwaysComparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors.The complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS.Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinomaDynamics and function of CXCR4 in formation of the granule cell layer during hippocampal development.Big opportunities for small molecules in immuno-oncology.Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices.Discovery and computer aided potency optimization of a novel class of small molecule CXCR4 antagonists.The intricate role of CXCR4 in cancer.Inhibition of angiogenesis, fibrosis and thrombosis by tetramethylpyrazine: mechanisms contributing to the SDF-1/CXCR4 axis.Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: potential biological and therapeutic implications.Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic MalignanciesImpact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice.Structural characterization and in vivo evaluation of β-Hairpin peptidomimetics as specific CXCR4 imaging agentsImproving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis.Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancerFunction-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitorsTrial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.Metastatic biomarkers in synovial sarcoma.Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement.Haematopoietic stem cell niches: new insights inspire new questions.CXCL12-CXCR4 contributes to the implication of bone marrow in cancer metastasis.SDF-1 signaling: a promising target in rheumatic diseases.The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease.Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists.T cell specific Cxcr5 deficiency prevents rheumatoid arthritis.Successes and failures of chemokine-pathway targeting in rheumatoid arthritis.Chloroquine-Modified Hydroxyethyl Starch as a Polymeric Drug for Cancer Therapy.Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.Identification of novel 2-(1H-indol-1-yl)-benzohydrazides CXCR4 ligands impairing breast cancer growth and motility.Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.A systematic approach to prioritize drug targets using machine learning, a molecular descriptor-based classification model, and high-throughput screening of plant derived molecules: a case study in oral cancer.CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer.Metal complexes of pyridine-fused macrocyclic polyamines targeting the chemokine receptor CXCR4.The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity.
P2860
Q26738538-83FB3575-934D-4813-9DE1-25D66A2799D2Q26782778-1167A6EF-49BF-4E9A-95AE-AA3D77986EDCQ26866236-0D40CD5E-1D6D-4160-A8E4-489254179C40Q28084663-1046E69E-1B07-4825-A5E9-D815989B2E53Q30572945-93817332-F4BB-469E-9B67-70B913E85544Q33565687-4AB2278F-A74B-4981-A20E-9BB04FB6C883Q33705883-387DA715-F154-4531-8A3A-1BF231C89314Q33775283-B1CC1FC0-FA6B-4D89-BFCD-A0E53FAAB4E5Q33911801-FC1FBDB7-8A3E-44BF-B3AC-77964B021D3FQ34487689-7537EE62-8D54-4C18-BD85-2855D615027EQ34537921-03721715-765D-4B51-89BE-F7E6C7832F2AQ35036663-287E451D-4C85-499E-9A1F-21BEF49D3AEEQ35067624-DEFE08D8-DB3B-41BD-A21E-2CD4CE51E853Q35088560-076F8B9F-D574-4810-9CDD-D6F2B2406065Q35216669-763E8988-5BF0-49D2-81C0-54C779406693Q35597598-049F8747-795F-438F-94BF-4770F515FAC1Q35949372-C2F8F7E9-029D-4DC7-8DD7-A5B88787796DQ35964652-15B5F7E5-13C8-420C-9F65-F5F3F8C44C35Q36181993-C34A934E-49AE-470D-87CB-7FC936BE06B4Q36249853-CFF22283-4E4B-4DAA-8925-E740705D39DDQ36293646-53A6E2A1-2304-44C4-95B2-AE3A52ABEF58Q36775158-7D69EEDE-7EB4-44C7-8CFD-80E537FFD469Q37079141-86CCACEC-4E2F-45AF-A7E3-ADA470B98B84Q37630943-245353A6-06E0-446D-BA1F-CBA56CD781AFQ37642643-954CA571-3A6C-4E85-8091-05094F1C9AA5Q38136093-BB43BB72-564C-4581-911C-870DFAB2D09BQ38209604-7EF4ACB5-B0CF-4D12-9125-0E0953730C90Q38221918-7C5EB59E-EF15-42E3-A734-769FB38B9DC3Q38223391-570A9A51-BB23-4D59-8C10-5350280E0525Q38542935-FA61841E-7E47-4084-9EC5-0161B09220F5Q38615369-B5BF0DB2-1A83-481C-AF8F-FF4C2E6B8F0BQ38647749-39279A1B-CC1D-4C5C-8338-679CDDA337F2Q38657644-B00B2C45-B445-44B5-95A6-88E31204A1B3Q38719813-8FD6125E-0873-4BE4-9038-0A74E01D34D6Q38799672-E9D1DAFB-BF75-431B-ADA5-B505550961BBQ38805564-0A9E7A16-AFD3-472B-988E-670B59C953E4Q38827863-2AB1D027-C8BC-40CD-8913-6A7EA5922676Q38831871-CE052EEC-A4D0-48F5-A3A6-EF97F8BBB89EQ38838107-80499509-EF1C-44D0-BEF5-27E86A0711BEQ38876206-68E90BB7-5A7C-4EA7-B0FB-75B7A4A2AA58
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Small molecule inhibitors of CXCR4.
@ast
Small molecule inhibitors of CXCR4.
@en
Small molecule inhibitors of CXCR4.
@nl
type
label
Small molecule inhibitors of CXCR4.
@ast
Small molecule inhibitors of CXCR4.
@en
Small molecule inhibitors of CXCR4.
@nl
prefLabel
Small molecule inhibitors of CXCR4.
@ast
Small molecule inhibitors of CXCR4.
@en
Small molecule inhibitors of CXCR4.
@nl
P2860
P50
P921
P356
P1433
P1476
Small molecule inhibitors of CXCR4
@en
P2093
Bikash Debnath
Nouri Neamati
P2860
P356
10.7150/THNO.5376
P577
2013-01-15T00:00:00Z